Golden
Arpeggio Biosciences

Arpeggio Biosciences

A a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

All edits

Edits on 6 Sep 2019
Golden AI
Golden AI edited on 6 Sep 2019 4:36 pm
Edits made to:
Infobox (+1 properties)
Edits on 29 Aug 2019
Golden AI
Golden AI edited on 29 Aug 2019 6:55 pm
Edits made to:
Infobox (+1 properties)
Edits on 19 Aug 2019
Mitchell Duffy
Mitchell Duffy edited on 19 Aug 2019 8:40 am
Edits made to:
Article (+15/-23 characters)

Article

The companies drug screening platform is can be used by scientists performing research related to dugdrug discovery and the mechanisms of actionsaction underlying the effectiveness of drugs. The drug screening platform provides time series profiling of drug compounds using RNA-profiling technology to gain insight into how thousands of genes are interacting within the human body. The company thanthen uses machine learning algorithms to analyze the time series profile to discover causal signalling networks, which can give researchers insight into the underlying mechanisms of action for their drugs, and help them predict about how a certain drug will affect a patient. 

Edits on 16 Aug 2019
Jed Christiansen
Jed Christiansen edited on 16 Aug 2019 10:11 pm
Edits made to:
Infobox (+3 properties)

Infobox

Company status
Active
Accelerator
Accelerator Batch
Edits on 13 Aug 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 13 Aug 2019 5:54 pm
Edits made to:
Article (+17/-17 characters)

Article

Arpeggio Biosciences is a biotechnology company headquartered in Boulder, ColoradoBoulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is located in the BioFrontiers Institute in the University of Boulder Colorado. The company is developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Will Suter
Will Suter approved a suggestion from Golden's AI on 13 Aug 2019 5:48 pm
Edits made to:
Article (+14/-14 characters)

Article

Arpeggio Biosciences is a biotechnology company headquartered in Boulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is located in the BioFrontiers Institute in the University of Boulder Colorado. The company is developing a drug-screening platform for the acceleration of drug discoverydrug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Dawson Sewell
Dawson Sewell edited on 13 Aug 2019 12:59 pm
Edits made to:
Infobox (+5 properties)
Description (+1/-23 characters)
Article (+1104 characters)
Topic thumbnail

Arpeggio Biosciences

Arpeggio Biosciences isA a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Article

Arpeggio Biosciences is a biotechnology company headquartered in Boulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is located in the BioFrontiers Institute in the University of Boulder Colorado. The company is developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Drug screening

The companies drug screening platform is can be used by scientists performing research related to dug discovery and the mechanisms of actions underlying the effectiveness of drugs. The drug screening platform provides time series profiling of drug compounds using RNA-profiling technology to gain insight into how thousands of genes are interacting within the human body. The company than uses machine learning algorithms to analyze the time series profile to discover causal signalling networks which can give researchers insight into the underlying mechanisms of action for their drugs, and help them predict about how a certain drug will affect a patient. 

Infobox

Date incorporated
2017
Edits on 5 Jul 2019
Melanie Manipula
Melanie Manipula edited on 5 Jul 2019 7:12 am
Edits made to:
Infobox (+5 properties)
Description (+205 characters)
People (+1 rows) (+2 cells) (+13 characters)
Categories (+2 topics)
Topic thumbnail

Arpeggio Biosciences

Arpeggio Biosciences is a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

People

Name
Role
Related Golden topics

Dan Weaver

CEO



Infobox

Categories

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 5 Jul 2019 6:45 am
Edits made to:
Topic thumbnail

 Arpeggio Biosciences

A a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

No more activity to show.